Search research articles
Contact Us
Filters
Showing results (111-120 of 308) with videos related to
Page
of 31
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 8, 2014
Changes in mortality patterns following total hip or knee arthroplasty over the past two decades: a nationwide cohort study
Arief Lalmohamed, Peter Vestergaard, Anthonius de Boer, et al.
British Journal of Clinical Pharmacology
|
July 27, 2022
Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study
Mirjam Hempenius, Simone Rijken, Rolf H H Groenwold, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
September 20, 2024
The minimal important difference in obsessive-compulsive disorder: An analysis of double-blind SSRI trials in adults
Sem E Cohen, Jasper B Zantvoord, Taina K Mattila, et al.
Pharmacoepidemiology and Drug Safety
|
June 16, 2020
Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study
Turki A Althunian, Anthonius de Boer, Rolf H H Groenwold, et al.
British Journal of Clinical Pharmacology
|
June 21, 2005
Suboptimal choices and dosing of statins at start of therapy
Aukje K Mantel-Teeuwisse, Olaf H Klungel, Tom Schalekamp, et al.
Pharmacoepidemiology and Drug Safety
|
October 26, 2007
Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods
Edwin P Martens, Anthonius de Boer, Wiebe R Pestman, et al.
Clinical Pharmacology and Therapeutics
|
June 13, 2006
CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring?
Tom Schalekamp, Gerard J J Boink, Loes E Visser, et al.
European Journal of Heart Failure
|
October 16, 2010
Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failure
Olav R de Peuter, Patrick C Souverein, Olaf H Klungel, et al.
Pharmacoepidemiology and Drug Safety
|
May 28, 2015
Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol
Miriam Jacoba Warnier, Frans Hendrik Rutten, Patrick Cyriel Souverein, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
June 9, 2009
Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes
Ozlem Bozkurt, Anthonius de Boer, Diederik E Grobbee, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 308) with videos related to
Sort By:
Page
of 31
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 8, 2014
Changes in mortality patterns following total hip or knee arthroplasty over the past two decades: a nationwide cohort study
Arief Lalmohamed, Peter Vestergaard, Anthonius de Boer, et al.
British Journal of Clinical Pharmacology
|
July 27, 2022
Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study
Mirjam Hempenius, Simone Rijken, Rolf H H Groenwold, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
September 20, 2024
The minimal important difference in obsessive-compulsive disorder: An analysis of double-blind SSRI trials in adults
Sem E Cohen, Jasper B Zantvoord, Taina K Mattila, et al.
Pharmacoepidemiology and Drug Safety
|
June 16, 2020
Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study
Turki A Althunian, Anthonius de Boer, Rolf H H Groenwold, et al.
British Journal of Clinical Pharmacology
|
June 21, 2005
Suboptimal choices and dosing of statins at start of therapy
Aukje K Mantel-Teeuwisse, Olaf H Klungel, Tom Schalekamp, et al.
Pharmacoepidemiology and Drug Safety
|
October 26, 2007
Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods
Edwin P Martens, Anthonius de Boer, Wiebe R Pestman, et al.
Clinical Pharmacology and Therapeutics
|
June 13, 2006
CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring?
Tom Schalekamp, Gerard J J Boink, Loes E Visser, et al.
European Journal of Heart Failure
|
October 16, 2010
Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failure
Olav R de Peuter, Patrick C Souverein, Olaf H Klungel, et al.
Pharmacoepidemiology and Drug Safety
|
May 28, 2015
Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol
Miriam Jacoba Warnier, Frans Hendrik Rutten, Patrick Cyriel Souverein, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
June 9, 2009
Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes
Ozlem Bozkurt, Anthonius de Boer, Diederik E Grobbee, et al.
Page
of 31